ESRRA and metabolic dysfunction-associated steatotic liver disease: Here, we preliminarily assessed the side effects of XCT790 in HFD-induced liver lesion, as it has been previously reported that liver-specific ERRα-deficient affects the development of liver steatosis and fibrosis, which may lead to non-alcoholic fatty liver disease (NAFLD)26.